Verrica Pharmaceuticals Inc. (VRCA): Capital Expenditures
$0
Year ended 2025-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | -100.0% | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | $27.0K | -92.5% | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | $362.0K | +19.9% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $302.0K | -65.8% | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | $883.0K | -39.9% | 2023-03-06, From 2021-01-01 |
| 2020-12-31 | $1.47M | +115.5% | 2022-03-02, From 2020-01-01 |
| 2019-12-31 | $682.0K | -11.9% | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | $774.0K | n/a | 2020-03-13, From 2018-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $0 | -100.0% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $756.6K | +0.5% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $174.5K | -89.5% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $2.35M | -16.9% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $121.6K | -61.2% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $1.57M | +552.4% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $567.0K | -89.1% |
| Verastem, Inc. (VSTM) | 2024-12-31 | $28.0K | n/a |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $50.0K | -94.5% |
Compare VRCA, ETST, SBFM, BHST side by side · Screen every company in Pharmaceutical Preparations ↗